<DOC>
	<DOC>NCT02649309</DOC>
	<brief_summary>This trial is a 2 x 2 factorial design, double-blinded, randomized controlled trial to evaluate efficacy and safety of remote ischemic preconditioning and postconditioning in patient undergoing coronary angioplasty.</brief_summary>
	<brief_title>Single-cycle Remote Ischemic Preconditioning and Postconditioning (SCRIP) Trial</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<criteria>Eligible for percutaneous coronary intervention (elective and emergency cases) Age &gt; 18yearold Informed consent Previous CABG Previous PCI in 1 week / treatment with thrombolysis within 30 days Peripheral arterial disease / AV shunt of upper extremities (AVF for hemodialysis) Paresis of upper limb Unstable patient such as cardiogenic shock / vasopressor / IABP / cooling (hypothermia) Fatal cardiac arrhythmia (VT / VF) Chronic hypoxia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Ischemic Preconditioning</keyword>
	<keyword>Postconditioning</keyword>
	<keyword>Angioplasty</keyword>
</DOC>